ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Warfarin pharmacogenetics

Johnson, Julie A.*; Cavallari, Larisa H.
Trends in Cardiovascular Medicine2015-1DOI: 10.1016/j.tcm.2014.09.001
115被引5阅读
引用收藏
分享

摘要

The cytochrome P450 (GYP) 2C9 and vitamin K epoxide reductase complex 1 (VKORC1) genotypes have been strongly and consistently associated with warfarin dose requirements, and dosing algorithms incorporating genetic and clinical information have been shown to be predictive of stable warfarin dose. However, clinical trials evaluating genotype-guided warfarin dosing produced mixed results, calling into question the utility of this approach. Recent trials used surrogate markers as endpoints rather than clinical endpoints, further complicating translation of the data to clinical practice. The present data do not support genetic testing to guide warfarin dosing, but in the setting where genotype data are available, use of such data in those of European ancestry is reasonable. Outcomes data are expected from an on-going trial, observational studies continue, and more work is needed to define dosing algorithms that incorporate appropriate variants in minority populations; all these will further shape guidelines and recommendations on the clinical utility of genotype-guided warfarin dosing.

学科与关键词

关键词
ACUTE VENOUS THROMBOEMBOLISMGENOME-WIDE ASSOCIATIONAFRICAN-AMERICANSGENETIC-VARIANTSHEMORRHAGIC COMPLICATIONSDOSE REQUIREMENTSVKORC1 GENOTYPESCYP2C9MAINTENANCEALGORITHMS
相关
加载中…
  • Pharmacogenetics of warfarin: challenges and opportunities
    Lee, Ming Ta Michael*; Klein, Teri E.Journal of Human Genetics, 2013, 58(6): 334-338.被引 83
  • Warfarin pharmacogenetics: A controlled dose-response study in healthy subjects
    Kadian-Dodov, Daniella L.*; van der Zee, Sarina A.; Scott, Stuart A.; Peter, Inga; Martis, Suparna; Doheny, Dana O.; Rothlauf, Elizabeth B.; Lubitz, Steven A.; Desnick, Robert J.; Halperin, Jonathan L.VASCULAR MEDICINE, 2013, 18(5): 290-297.被引 7
  • Warfarin Pharmacogenetics: New Life for an Old Drug
    Wen, Ming-Shien; Lee, Ming Ta Michael*Acta Cardiologica Sinica, 2013, 29(3): 235-242.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
Trends in Cardiovascular Medicine
发表日期
2015-01
卷期
第 25 卷, 第 1 期
页码
33-41
DOI
10.1016/j.tcm.2014.09.001
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q2
成果收录
SCIE
资助标注
NIH, USA [U01 GM074492, U01 HG007269]

作者

  • J

    Johnson, Julie A. (通讯) (第一作者)

  • C

    Cavallari, Larisa H.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417